| |
 |
ARTICLES 
|
|
| The role of marrow transplantation in acute lymphoblastic leukemia |
| JH Kersey |
|
JCO Nov 1 1989: 1589–1590.
[PDF]
|
 |
| Stage IV non-small-cell lung cancer: the guides are perplexed |
| RB Livingston |
|
JCO Nov 1 1989: 1591–1593.
[PDF]
|
|
|
Autologous bone marrow transplantation for acute lymphoblastic leukemia |
| |
SE Sallan, CM Niemeyer, AL Billett, JM Lipton, NJ Tarbell, RD Gelber, C Murray, TP Pittinger, LC Wolfe, and RC Bast, Jr |
| |
JCO Nov 1 1989: 1594–1601.
[Abstract]
[PDF]
|
|
|
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group |
| |
PD Bonomi, DM Finkelstein, JC Ruckdeschel, RH Blum, MD Green, B Mason, R Hahn, DC Tormey, J Harris, and R Comis |
| |
JCO Nov 1 1989: 1602–1613.
[Abstract]
[PDF]
|
|
|
Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features |
| |
HH Berendsen, L de Leij, S Poppema, PE Postmus, A Boes, HJ Sluiter, and H The |
| |
JCO Nov 1 1989: 1614–1620.
[Abstract]
[PDF]
|
|
|
Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy |
| |
JG Gribben, AH Goldstone, DC Linch, G Taghipour, AK McMillan, RL Souhami, H Earl, and JD Richards |
| |
JCO Nov 1 1989: 1621–1629.
[Abstract]
[PDF]
|
|
|
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting [published erratum appears in J Clin Oncol 1990 Sep;8(9):1602] |
| |
TA Lister, D Crowther, SB Sutcliffe, E Glatstein, GP Canellos, RC Young, SA Rosenberg, CA Coltman, and M Tubiana |
| |
JCO Nov 1 1989: 1630–1636.
[Abstract]
[PDF]
|
|
|
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome |
| |
JL Gajewski, WG Ho, SD Nimer, KF Hirji, L Gekelman, AD Jacobs, and RE Champlin |
| |
JCO Nov 1 1989: 1637–1645.
[Abstract]
[PDF]
|
|
|
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial |
| |
DC Hohn, RJ Stagg, MA Friedman, JF Hannigan, Jr, A Rayner, RJ Ignoffo, P Acord, and BJ Lewis |
| |
JCO Nov 1 1989: 1646–1654.
[Abstract]
[PDF]
|
|
|
Ifosfamide plus doxorubicin in metastatic adult sarcomas: a multi- institutional phase II trial |
| |
Sr Loehrer PJ, GW Sledge, Jr, C Nicaise, J Usakewicz, JD Hainsworth, OJ Martelo, G Omura, and TJ Braun |
| |
JCO Nov 1 1989: 1655–1659.
[Abstract]
[PDF]
|
|
|
Neurodevelopmental status of infants and young children treated for brain tumors with preirradiation chemotherapy |
| |
RK Mulhern, ME Horowitz, EH Kovnar, J Langston, RA Sanford, and LE Kun |
| |
JCO Nov 1 1989: 1660–1666.
[Abstract]
[PDF]
|
|
|
Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group |
| |
GJ Rustin, JN Gennings, AE Nelstrop, H Covarrubias, HE Lambert, and KD Bagshawe |
| |
JCO Nov 1 1989: 1667–1671.
[Abstract]
[PDF]
|
|
|
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study |
| |
GP Sutton, JA Blessing, HD Homesley, ML Berman, and J Malfetano |
| |
JCO Nov 1 1989: 1672–1676.
[Abstract]
[PDF]
|
|
|
Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma |
| |
PT Ang, AU Buzdar, TL Smith, S Kau, and GN Hortobagyi |
| |
JCO Nov 1 1989: 1677–1684.
[Abstract]
[PDF]
|
|
|
Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation |
| |
J Neidhart, A Mangalik, W Kohler, C Stidley, J Saiki, P Duncan, L Souza, and M Downing |
| |
JCO Nov 1 1989: 1685–1692.
[Abstract]
[PDF]
|
|
|
Protection from nausea and vomiting in cisplatin-treated patients: high- dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research |
| |
F Roila, M Tonato, C Basurto, M Picciafuoco, S Bracarda, D Donati, P Malacarne, L Monici, F Di Costanzo, and L Patoia |
| |
JCO Nov 1 1989: 1693–1700.
[Abstract]
[PDF]
|
|
|
Relapse in the central nervous system in melanoma patients successfully treated with biomodulators |
| |
MS Mitchell |
| |
JCO Nov 1 1989: 1701–1709.
[Abstract]
[PDF]
|
|
|
Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer |
| |
R von Roemeling and WJ Hrushesky |
| |
JCO Nov 1 1989: 1710–1719.
[Abstract]
[PDF]
|
|
|
Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma |
| |
LJ Helman, PS Cohen, SD Averbuch, MJ Cooper, HR Keiser, and MA Israel |
| |
JCO Nov 1 1989: 1720–1725.
[Abstract]
[PDF]
|
|
|
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study |
| |
KH Lee, M Talpaz, JM Rothberg, JL Murray, N Papadopoulos, C Plager, R Benjamin, D Levitt, and J Gutterman |
| |
JCO Nov 1 1989: 1726–1732.
[Abstract]
[PDF]
|
|
|
Clinical pharmacology of a novel diarylsulfonylurea anticancer agent |
| |
CW Taylor, DS Alberts, MA Ketcham, WG Satterlee, MT Holdsworth, PM Plezia, YM Peng, TM McCloskey, DJ Roe, and M Hamilton |
| |
JCO Nov 1 1989: 1733–1740.
[Abstract]
[PDF]
|
|
|
Variability in the disposition of intraventricular methotrexate: a proposal for rational dosing |
| |
DR Strother, A Glynn-Barnhart, E Kovnar, RE Gregory, and SB Murphy |
| |
JCO Nov 1 1989: 1741–1747.
[Abstract]
[PDF]
|
|
|
Carboplatin dosage: prospective evaluation of a simple formula based on renal function |
| |
AH Calvert, DR Newell, LA Gumbrell, S O'Reilly, M Burnell, FE Boxall, ZH Siddik, IR Judson, ME Gore, and E Wiltshaw |
| |
JCO Nov 1 1989: 1748–1756.
[Abstract]
[PDF]
|
|
